EFG Asset Management (Americas)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.37M | Sell |
4,888
-490
| -9% | -$228K | 0.41% | 78 |
|
|
2025
Q2 | $2.18M | Sell |
5,378
-4,784
| -47% | -$2M | 0.4% | 73 |
|
|
2025
Q1 | $5.06M | Sell |
10,162
-175
| -2% | -$94.8K | 1.02% | 32 |
|
|
2024
Q4 | $5.38M | Sell |
10,337
-137
| -1% | -$75.3K | 1.05% | 32 |
|
|
2024
Q3 | $6.48M | Sell |
10,474
-500
| -5% | -$296K | 1.27% | 28 |
|
|
2024
Q2 | $6.07M | Buy |
10,974
+3,258
| +42% | +$1.87M | 1.19% | 27 |
|
|
2024
Q1 | $4.48M | Sell |
7,716
-3,269
| -30% | -$1.83M | 1.36% | 27 |
|
|
2023
Q4 | $5.83M | Sell |
10,985
-230
| -2% | -$111K | 1.26% | 27 |
|
|
2023
Q3 | $5.68M | Buy |
11,215
+1,520
| +16% | +$810K | 1.36% | 23 |
|
|
2023
Q2 | $5.06M | Sell |
9,695
-502
| -5% | -$271K | 1.17% | 26 |
|
|
2023
Q1 | $5.88M | Sell |
10,197
-1,327
| -12% | -$748K | 1.41% | 22 |
|
|
2022
Q4 | $6.35M | Sell |
11,524
-754
| -6% | -$400K | 1.57% | 24 |
|
|
2022
Q3 | $6.25M | Sell |
12,278
-1,117
| -8% | -$625K | 1.58% | 18 |
|
|
2022
Q2 | $7.29M | Sell |
13,395
-558
| -4% | -$307K | 1.72% | 22 |
|
|
2022
Q1 | $8.26M | Sell |
13,953
-5,067
| -27% | -$2.91M | 1.53% | 22 |
|
|
2021
Q4 | $12.7M | Sell |
19,020
-5,013
| -21% | -$3.13M | 2.14% | 11 |
|
|
2021
Q3 | $13.8M | Buy |
24,033
+1,171
| +5% | +$643K | 2.45% | 9 |
|
|
2021
Q2 | $11.6M | Buy |
22,862
+72
| +0.3% | +$34K | 2.15% | 10 |
|
|
2021
Q1 | $10.4M | Buy |
22,790
+742
| +3% | +$354K | 2.13% | 10 |
|
|
2020
Q4 | $10.3M | Buy |
22,048
+219
| +1% | +$103K | 2.1% | 10 |
|
|
2020
Q3 | $9.63M | Buy |
21,829
+801
| +4% | +$331K | 2.17% | 8 |
|
|
2020
Q2 | $7.62M | Buy |
21,028
+97
| +0.5% | +$32.5K | 1.98% | 11 |
|
|
2020
Q1 | $5.94M | Buy |
20,931
+1,050
| +5% | +$331K | 1.9% | 14 |
|
|
2019
Q4 | $6.46M | Buy |
19,881
+744
| +4% | +$226K | 1.7% | 16 |
|
|
2019
Q3 | $5.57M | Buy |
19,137
+332
| +2% | +$95.1K | 1.68% | 16 |
|
|
2019
Q2 | $5.52M | Buy |
18,805
+465
| +3% | +$128K | 1.57% | 15 |
|
|
2019
Q1 | $5.02M | Buy |
18,340
+607
| +3% | +$151K | 1.52% | 18 |
|
|
2018
Q4 | $3.97M | Buy |
17,733
+4,256
| +32% | +$999K | 1.43% | 19 |
|
|
2018
Q3 | $3.29M | Buy |
13,477
+984
| +8% | +$226K | 0.94% | 43 |
|
|
2018
Q2 | $2.59M | Buy |
12,493
+1,901
| +18% | +$404K | 0.78% | 41 |
|
|
2018
Q1 | $2.19M | Buy |
+10,592
| New | +$2.22M | 0.91% | 34 |
|
|
2016
Q3 | – | Sell |
-9,961
| Closed | -$1.49M | – | 125 |
|
|
2016
Q2 | $1.49M | Sell |
9,961
-369
| -4% | -$54.5K | 0.7% | 41 |
|
|
2016
Q1 | $1.48M | Sell |
10,330
-522
| -5% | -$70K | 0.74% | 40 |
|
|
2015
Q4 | $1.4M | Buy |
10,852
+383
| +4% | +$51.1K | 0.87% | 35 |
|
|
2015
Q3 | $1.29M | Buy |
10,469
+5,364
| +105% | +$699K | 0.81% | 31 |
|
|
2015
Q2 | $672K | Buy |
5,105
+1,748
| +52% | +$228K | 0.41% | 44 |
|
|
2015
Q1 | $451K | Sell |
3,357
-45
| -1% | -$5.8K | 0.35% | 44 |
|
|
2014
Q4 | $433K | Buy |
3,402
+1,843
| +118% | +$224K | 0.26% | 53 |
|
|
2014
Q3 | $191K | Buy |
+1,559
| New | +$190K | 0.19% | 35 |
|
Other funds holding TMO
EFG Asset Management (Americas)'s TMO Position: Q3 2025 in Review
EFG Asset Management (Americas) reduced its Thermo Fisher Scientific (TMO) stake by 9.1% in Q3 2025, selling an estimated $228K and leaving 4,888 shares worth $2.37M. The position accounts for 0.41% of the portfolio, ranked #78.
EFG Asset Management (Americas) first reported a position in TMO in Q3 2014 and has held it in 39 quarters since. The position peaked at $13.8M in Q3 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- EFG Asset Management (Americas) held 4,888 shares of Thermo Fisher Scientific worth $2.37M as of Q3 2025.
- EFG Asset Management (Americas) sold 490 Thermo Fisher Scientific shares in Q3 2025, an estimated $228K.
- Thermo Fisher Scientific made up 0.41% of EFG Asset Management (Americas)'s portfolio in Q3 2025, its #78 holding.
- EFG Asset Management (Americas) first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 39 quarters since.
- EFG Asset Management (Americas)'s Thermo Fisher Scientific position peaked at $13.8M in Q3 2021.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on EFG Asset Management (Americas)'s 13F filing for Q3 2025, filed 14 Nov 2025.